TNF Blockers News and Research

RSS
UCB to present new data on Cimzia at ACG annual scientific meeting

UCB to present new data on Cimzia at ACG annual scientific meeting

Janssen Biotech receives FDA approval for Remicade to treat UC in children

Janssen Biotech receives FDA approval for Remicade to treat UC in children

Janssen receives FDA Complete Response letter for SIMPONI sBLA to treat RA

Janssen receives FDA Complete Response letter for SIMPONI sBLA to treat RA

GIDAC recommends FDA approval of Janssen's REMICADE for treatment of pediatric UC

GIDAC recommends FDA approval of Janssen's REMICADE for treatment of pediatric UC

New genetic research on Ankylosing Spondylitis

New genetic research on Ankylosing Spondylitis

Humira defect lawyers file suit against Abbott Laboratories in federal court

Humira defect lawyers file suit against Abbott Laboratories in federal court

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

Amgen, Pfizer present Enbrel new trial results against psoriasis at 69th AAD meeting in New Orleans, LA

Amgen, Pfizer present Enbrel new trial results against psoriasis at 69th AAD meeting in New Orleans, LA

Inflammation “master switch” found: Study

Inflammation “master switch” found: Study

Centocor Ortho Biotech files REMICADE sBLA for ulcerative colitis in pediatric patients

Centocor Ortho Biotech files REMICADE sBLA for ulcerative colitis in pediatric patients

CGEN-15001 administration shows dramatic therapeutic potential in CIA animal model

CGEN-15001 administration shows dramatic therapeutic potential in CIA animal model

Abbott presents results of 2 pivotal HUMIRA studies at American College of Rheumatology meeting

Abbott presents results of 2 pivotal HUMIRA studies at American College of Rheumatology meeting

SIMPONI injection improves inflammation, structural damage in RA patients

SIMPONI injection improves inflammation, structural damage in RA patients

UCB presents P3, P4 clinical trial data for Crohn's disease at ACG Scientific Meeting

UCB presents P3, P4 clinical trial data for Crohn's disease at ACG Scientific Meeting

ACG meeting to exhibit Cimzia data for Crohn's disease treatment

ACG meeting to exhibit Cimzia data for Crohn's disease treatment

Immunosuppressive properties of TNF blockers may increase risk of malignancy in children

Immunosuppressive properties of TNF blockers may increase risk of malignancy in children

TNF blockers may increase the risk of malignancy in children

TNF blockers may increase the risk of malignancy in children

New data on Cimzia for Crohn’s Disease treatment to be demonstrated at DDW 2010

New data on Cimzia for Crohn’s Disease treatment to be demonstrated at DDW 2010

Results of study comparing REMICADE to azathioprine for Crohn's disease published

Results of study comparing REMICADE to azathioprine for Crohn's disease published